Who is sponsoring NCT05578105?

NCT05578105 is sponsored by National Taiwan University Hospital.

What drugs are being tested in NCT05578105?

Interventions in NCT05578105: no intervention.

What condition does NCT05578105 study?

NCT05578105 studies Autoimmune Polyendocrine Syndrome Type II.

Is NCT05578105 still recruiting?

NCT05578105 is currently recruiting now. Last updated 13 October 2022.

Last reviewed 2022-10-13 · How we verify

NCT05578105

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Prevalence and Genetic Alternation of Autoimmune Polyglandular Syndrome Type II in Taiwan

Recruiting now Last updated 13 October 2022

What this trial tests

trial testing no intervention in Autoimmune Polyendocrine Syndrome Type II in 650 participants. Currently enrolling.

Timeline

1 January 2022

Primary endpoint
31 December 2026

31 December 2026

Quick facts

Lead sponsor	National Taiwan University Hospital
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	650
Start date	1 January 2022
Primary completion	31 December 2026
Estimated completion	31 December 2026
Sites	1 location across Taiwan

Drugs / interventions tested

no intervention

Conditions studied

Autoimmune Polyendocrine Syndrome Type II — all drugs for Autoimmune Polyendocrine Syndrome Type II →

Sponsor

National Taiwan University Hospital

Who can join

20 and older, any sex, with Autoimmune Polyendocrine Syndrome Type II. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Autoimmune polyendocrine syndrome (APS) is an autoimmune disease involving at least two endocrine organ. It is classified into type I and type II diseases. Among them, APS type II is more common. It is diagnosed when two of the three following diseases are diagnosed in the same patient, including type 1 diabetes mellitus, autoimmune thyroid disease, and primary adrenal insufficiency. In this study, we will observe the epidemiology, clinical characteristics, and genetic variants of APS II in Taiwan.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

A 20-year study of autoimmune polyendocrine syndrome type II and III in Taiwan.
Tseng HH, Lin YB, Lin KY, Lin CH, et al · · 2023 · cited 2× · PMID 37878416 · DOI 10.1530/etj-23-0162

Verify or expand the search:

Other trials of no intervention

Trials testing the same drug.

NCT07480057 — Assessment of Changes in Bone Mineral Metabolism After Liver Transplantation by Bone Mineral Densitometry · recruiting
NCT07253506 — Turkish Adaptation, Validity, and Reliability Study of the Patient Experience With Treatment and Self-Management Scale i · not yet recruiting
NCT07253519 — The Relationship Between Mood and Insomnia Severity and Caregiver Burden in Caregivers of Stroke · not yet recruiting
NCT07194096 — Stress Hyperglycemia Ratio and Postoperative Delirium · not yet recruiting
NCT07240337 — Botulinum Toxin Applications in Hemiplegic Patients · recruiting

Other National Taiwan University Hospital trials

Trials by the same sponsor.

NCT06936917 — Timing for Computed Tomography and Post-Resuscitation Care on Short-Term Outcomes in Out-of-Hospital Cardiac Arrest · not yet recruiting
NCT05396222 — A Prospective Study of the Safety and Efficacy of 3D-printed Non-rigid Biomimetic Implant in Cervical and Thoracolumbar · NA · not yet recruiting
NCT07532356 — Integrating Tumor Genomics and Urinary Exosomal Proteomics to Establish a Multi-Layer Biomarker Framework for Early Risk · not yet recruiting
NCT07317310 — The NTU JO-SMART Study · NA · not yet recruiting
NCT07382024 — Tirzepatide to Reduce rEcurrence And Burden After Ablation of Atrial Fibrillation · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05578105 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by National Taiwan University Hospital
Last refreshed: 13 October 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05578105.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing